title: Efficacy of eculizumab in the treatment of recurrent atypical hemolytic-uremic syndrome after renal transplantation.
authors.forename: Carlos Fernández-de
authors.initials: CF
authors.lastname: Larrea
authors.forename: Frederic
authors.initials: F
authors.lastname: Cofan
authors.forename: Federico
authors.initials: F
authors.lastname: Oppenheimer
authors.forename: Josep Maria
authors.initials: JM
authors.lastname: Campistol
authors.forename: Gines
authors.initials: G
authors.lastname: Escolar
authors.forename: Miguel
authors.initials: M
authors.lastname: Lozano
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000009:adverse effects*; D010951:Plasma Exchange; D012008:Recurrence; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007155:Immunologic Factors; C481642:eculizumab